Abstract. Vitamin K antagonists (VKAs) are commonly used for the prevention and treatment of thrombotic disorders. The response to VKAs is highly variable due t
Key Points. Molecular MRD after induction chemotherapy identifies patients with NPM1 AML who benefit from allogeneic transplant in first remissionPatients
In this issue of Blood, Woyach et al1 report an update of a pivotal phase 3 trial showing the superiority of ibrutinib (Ibr)-based treatments over chemoimm
Kamya Sankar, Jacob Mercer, Ellen Jaeger, Jen Godden, Jonathan Berkman, Edward Williams, Michael Thompson, Shetal Patel, Karen Reckamp, Frank Weinberg Cedars-Sinai Medical Center, Tempus AI,…
A 63-year-old man presented with fever, splenomegaly, hyperferritinemia (10 798 ng/dL), elevated soluble interleukin-2R (6644 pg/mL), anemia (hemoglobin 6.9 g/dL), and thrombocytopenia (42 000/μL). Atypical…
Yuan Yuan, Irene Kang, Jin Sun Bitar, Andrew Davis, Christie Hilton, Minxuan Huang, Michael Thompson, Jacob Mercer, Stephen Shiao, Eric Vail Cedars-Sinai Medical Center, City…
Christine Ho Roswell Park Comprehensive Cancer Center, Buffalo, NY Christine Ho, Paul K. Wallace, Kristopher Attwood, Sarah Parker, Hemn Mohammadpour, Megan Herr, George Chen, Joseph…
Ghulam Rehman Mohyuddin University of Utah, Salt Lake City, UT Ghulam Rehman Mohyuddin, Jennifer M. Ahlstrom, Cynthia Chmielewski, Nathan W. Sweeney, Thomas H. Molina, Christian…
Sridurga Mithraprabhu Alfred Hospital / Monash University, Melbourne, Australia Sridurga Mithraprabhu, John Reynolds, Rose Turner, Anna Kalff, Krystal Bergin, HANG QUACH, Tiffany Khong, Brian G.…
